New medication – Eylea
Eylea – new medication for the patients with the wet form of AMD.
The medication Eylea is recommended to apply in adult patients to treat neovascular (exudative) form of age-related macular degeneration (AMD).
The effects consist in stopping the growth of new abnormal blood vessels in the eye, this may help in stabilization of the loss of vision related to the exudative form of AMD, and in many cases it may hinder it.